Rationally designed peptide nanosponges for cell-based cancer therapy

Nanomedicine. 2017 Nov;13(8):2555-2564. doi: 10.1016/j.nano.2017.07.004. Epub 2017 Jul 25.

Abstract

A novel type of supramolecular aggregate, named a "nanosponge" was synthesized through the interaction of novel supramolecular building blocks with trigonal geometry. The cholesterol-(K/D)nDEVDGC)3-trimaleimide unit consists of a trigonal maleimide linker to which homopeptides (either K or D) of variable lengths (n=5, 10, 15, 20) and a consensus sequence for executioner caspases (DEVDGC) are added via Michael addition. Upon mixing in aqueous buffer cholesterol-(K)nDEVDGC)3-trimaleimides and a 1:1 mixture of cholesterol-(K/D)nDEVDGC)3-trimaleimides form stable nanosponges, whereas cholesterol-(D)nDEVDGC)3-trimaleimide is unable to form supramolecular aggregates with itself. The structure of the novel nanosponges was investigated through explicit solvent and then coarse-grained molecular dynamics (MD) simulations. The nanosponges are between 80 nm and several micrometers in diameters and virtually non-toxic to monocyte/macrophage-like cells.

Keywords: Aggregation; Coarse-grained molecular dynamics simulations; Drug delivery; Explicit solvent molecular dynamics simulations; Nanomaterials; Nanosponges; Supramolecular.

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Cholesterol / analogs & derivatives*
  • Drug Carriers / chemistry*
  • Drug Delivery Systems
  • Humans
  • Mice
  • Molecular Dynamics Simulation
  • Nanostructures / chemistry*
  • Neoplasms / drug therapy
  • Peptides / chemistry*
  • RAW 264.7 Cells

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Peptides
  • Cholesterol